NO960223L - 2,9-disubstituerte purin-6-oner - Google Patents
2,9-disubstituerte purin-6-onerInfo
- Publication number
- NO960223L NO960223L NO960223A NO960223A NO960223L NO 960223 L NO960223 L NO 960223L NO 960223 A NO960223 A NO 960223A NO 960223 A NO960223 A NO 960223A NO 960223 L NO960223 L NO 960223L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- carbon atoms
- purln
- phenyl
- straight chain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/28—Oxygen atom
- C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Abstract
2,9-dlsubstltuerte purln-6-oner fremstilles ved at man l et første trinn acyleres tilsvarende substituerte aminolmidazoler og deretter rlngslutter til purln. De nye 2,9-disubstltuerte purln-6-onene kan anvendes som virksomme stoffer l legemidler, spesielt for behandling av betennelser, tromboemboliske, hjerte- og kretsløps- sykdommer og sykdommer l urogenltalsystemet. O): A står for en rest med formelen eller for rettkjedet eller forgrenet alkyl med Inntil 20 karbonatomer, eller for cykloalkyl med 3 til 7 karbonatomer eller står for fenyl som eventuelt kan vare substituert Inntil 2 ganger likt eller forskjellig med halogen, karboksyl. trlfluormetyl, nltro. cyano eller med rettkjedet eller forgrenet alkyl, alkoksykarbonyl eller alkoksy med l et hvert tilfelle Inntil 5 karbonatomer, som l sin tur kan vare substituert med fenyl, og/eller syklusene er eventuelt substituert med fenyl som l sin tur kan vare substituert med rettkjedet eller forgrenet alkoksy med Inntil 5 karbonatomer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19501482A DE19501482A1 (de) | 1995-01-19 | 1995-01-19 | 2,9-disubstituierte Purin-6-one |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO960223D0 NO960223D0 (no) | 1996-01-18 |
| NO960223L true NO960223L (no) | 1996-07-22 |
Family
ID=7751830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO960223A NO960223L (no) | 1995-01-19 | 1996-01-18 | 2,9-disubstituerte purin-6-oner |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US5861404A (no) |
| EP (1) | EP0722944A1 (no) |
| JP (1) | JPH08231545A (no) |
| KR (1) | KR960029334A (no) |
| CN (1) | CN1135485A (no) |
| AR (1) | AR002953A1 (no) |
| AU (1) | AU4097996A (no) |
| BG (1) | BG61728B1 (no) |
| BR (1) | BR9600147A (no) |
| CA (1) | CA2167353A1 (no) |
| CO (1) | CO4700523A1 (no) |
| CZ (1) | CZ16696A3 (no) |
| DE (1) | DE19501482A1 (no) |
| EE (1) | EE9600018A (no) |
| FI (1) | FI960225A (no) |
| HR (1) | HRP960007A2 (no) |
| HU (1) | HUP9600106A3 (no) |
| IL (1) | IL116769A (no) |
| MA (1) | MA23778A1 (no) |
| NO (1) | NO960223L (no) |
| NZ (1) | NZ280830A (no) |
| PE (1) | PE64996A1 (no) |
| PL (1) | PL312354A1 (no) |
| SG (1) | SG50401A1 (no) |
| SK (1) | SK8096A3 (no) |
| SV (1) | SV1996000006A (no) |
| TN (2) | TNSN96007A1 (no) |
| TR (1) | TR199600028A2 (no) |
| TW (1) | TW314519B (no) |
| YU (1) | YU1396A (no) |
| ZA (1) | ZA96398B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19529102A1 (de) * | 1995-08-08 | 1997-02-13 | Kummer Horst Dieter | Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen |
| US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| USRE37234E1 (en) | 1996-11-01 | 2001-06-19 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiestrase inhibitor compounds, compositions and their uses |
| US5958926A (en) | 1996-11-01 | 1999-09-28 | Nitromed, Inc. | Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| US6310070B1 (en) * | 1997-07-15 | 2001-10-30 | Japan Energy Corporation | Purine derivatives and medicinal use thereof |
| WO1999024432A1 (en) * | 1997-11-12 | 1999-05-20 | Mitsubishi Chemical Corporation | Purine derivatives and medicine containing the same as the active ingredient |
| EP1054012B1 (en) * | 1998-01-05 | 2003-06-11 | Eisai Co., Ltd. | Purine derivatives and adenosine a2 receptor antagonists serving as preventives/remedies for diabetes |
| US6268372B1 (en) | 1998-09-11 | 2001-07-31 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones |
| US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
| US6660745B1 (en) * | 1999-05-11 | 2003-12-09 | Mitsubishi Chemical Corporation | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof |
| GB9924020D0 (en) | 1999-10-11 | 1999-12-15 | Pfizer Ltd | Pharmaceutically active compounds |
| NZ524572A (en) * | 2000-09-06 | 2004-08-27 | Tanabe Seiyaku Co | Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions |
| US7927623B2 (en) * | 2001-02-15 | 2011-04-19 | Mitsubishi Tanabe Pharma Corporation | Tablets quickly disintegrated in oral cavity |
| US6479493B1 (en) | 2001-08-23 | 2002-11-12 | Cell Pathways, Inc. | Methods for treatment of type I diabetes |
| US7276529B2 (en) | 2002-03-20 | 2007-10-02 | Celgene Corporation | Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| US7893101B2 (en) | 2002-03-20 | 2011-02-22 | Celgene Corporation | Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof |
| US6962940B2 (en) | 2002-03-20 | 2005-11-08 | Celgene Corporation | (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| US7208516B2 (en) | 2002-03-20 | 2007-04-24 | Celgene Corporation | Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione |
| CN102742513A (zh) * | 2012-07-17 | 2012-10-24 | 南京熊猫机电制造有限公司 | 一种喂食栏装置 |
| US10300042B2 (en) | 2014-06-23 | 2019-05-28 | Celgene Corporation | Apremilast for the treatment of a liver disease or a liver function abnormality |
| AU2020256166A1 (en) | 2019-04-02 | 2021-10-14 | Aligos Therapeutics, Inc. | Compounds targeting PRMT5 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4451478A (en) * | 1982-03-12 | 1984-05-29 | Newport Pharmaceuticals International, Inc. | Imidazole compounds |
| IL76546A (en) * | 1984-10-12 | 1988-12-30 | Warner Lambert Co | 9-(heteroarylalkyl)-6-purine(thi)one derivatives,their preparation and pharmaceutical compositions containing them |
| GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
-
1995
- 1995-01-19 DE DE19501482A patent/DE19501482A1/de not_active Withdrawn
- 1995-12-27 TW TW084113907A patent/TW314519B/zh active
-
1996
- 1996-01-08 HR HR19501482.0A patent/HRP960007A2/hr not_active Application Discontinuation
- 1996-01-08 EP EP96100156A patent/EP0722944A1/de not_active Withdrawn
- 1996-01-12 YU YU1396A patent/YU1396A/sh unknown
- 1996-01-12 US US08/587,321 patent/US5861404A/en not_active Expired - Fee Related
- 1996-01-15 AU AU40979/96A patent/AU4097996A/en not_active Abandoned
- 1996-01-15 TR TR96/00028A patent/TR199600028A2/xx unknown
- 1996-01-16 IL IL11676996A patent/IL116769A/en not_active IP Right Cessation
- 1996-01-16 CA CA002167353A patent/CA2167353A1/en not_active Abandoned
- 1996-01-16 NZ NZ280830A patent/NZ280830A/en unknown
- 1996-01-17 TN TNTNSN96007A patent/TNSN96007A1/fr unknown
- 1996-01-17 TN TNTNSN96006A patent/TNSN96006A1/fr unknown
- 1996-01-17 PL PL96312354A patent/PL312354A1/xx unknown
- 1996-01-17 FI FI960225A patent/FI960225A/fi unknown
- 1996-01-17 SG SG1996000260A patent/SG50401A1/en unknown
- 1996-01-18 JP JP8023473A patent/JPH08231545A/ja active Pending
- 1996-01-18 BR BR9600147A patent/BR9600147A/pt active Search and Examination
- 1996-01-18 EE EE9600018A patent/EE9600018A/xx unknown
- 1996-01-18 NO NO960223A patent/NO960223L/no unknown
- 1996-01-18 BG BG100292A patent/BG61728B1/bg unknown
- 1996-01-18 HU HU9600106A patent/HUP9600106A3/hu unknown
- 1996-01-18 KR KR1019960001002A patent/KR960029334A/ko not_active Application Discontinuation
- 1996-01-18 CZ CZ96166A patent/CZ16696A3/cs unknown
- 1996-01-18 ZA ZA96398A patent/ZA96398B/xx unknown
- 1996-01-18 MA MA24133A patent/MA23778A1/fr unknown
- 1996-01-18 SK SK80-96A patent/SK8096A3/sk unknown
- 1996-01-19 AR ARP960101088A patent/AR002953A1/es unknown
- 1996-01-19 PE PE1996000043A patent/PE64996A1/es not_active Application Discontinuation
- 1996-01-19 CO CO96002169A patent/CO4700523A1/es unknown
- 1996-01-19 SV SV1996000006A patent/SV1996000006A/es unknown
- 1996-01-19 CN CN96101917A patent/CN1135485A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO960223L (no) | 2,9-disubstituerte purin-6-oner | |
| WO2005034952A3 (en) | Isoxazole and isothiazole compounds useful in the treatment of inflammation | |
| ATE495162T1 (de) | Azabicyclo-octan und nonan derivate mit ddp-iv hemmender wirkung | |
| ATE417051T1 (de) | Polymorphe von clopidogrel-hydrogensulfat | |
| PE20060335A1 (es) | Prolina cci-779, su produccion y sintesis enzimatica de dos etapas de prolina cci-779 y cci-779 | |
| NO20050570L (no) | Nye forbindelser, preparater og fremgangsmater for behandling av inflammasjonssykdommer og -tilstander | |
| NO20083739L (no) | Tieno-pyridinderivater som MEK-inhibitorer | |
| NO20062357L (no) | Indolinderivater og anvendelse av dem ved behandling av sykdomstilstander som cancer | |
| NO994256L (no) | Små molekyler som er anvendelige ved behandling av inflammasjonssykdom | |
| EA200401294A1 (ru) | Производные хинолина и изохинолина, способ их получения и их применение в качестве ингибиторов воспаления | |
| IS7550A (is) | Aðferð til framleiðslu á kvínólín-afleiðum | |
| DK0820438T3 (da) | O-carbamoyl-phenylalaninol med substituent på benzenringen, dens farmaceutisk egnede salte og fremgangsmåde til fremstilling af samme | |
| NO20071534L (no) | Behandling av inflammatoriske forstyrrelser og smerte | |
| NO20063576L (no) | 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes | |
| DK1023266T3 (da) | Fremgangsmåde til fremstilling af diarylpyridiner, der kan anvendes som COX-2-inhibitorer | |
| NO20013241L (no) | Celleadhesjon-hemmende antiinflammatoriske og immun- undertrykkende forbindelser | |
| ATE384722T1 (de) | Alkoxypyridinderivate | |
| DK0869965T3 (da) | Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler | |
| FR2841562B1 (fr) | Composition retardatrice d'inflammation, procede de preparation de cette composition, et procede de retardement d'incendies en terrain sauvage utilisant cette composition | |
| NO20051683L (no) | Intermediater ved fremstilling av fenoksyeddiksyrederivater samt fremgangsmate ved anvendelse av samme | |
| GEP20084477B (en) | NEW BENZAMIDES AS PPARγ MODULATORS | |
| GB910255A (en) | Benzodiazepine derivatives and a process for the manufacture of same | |
| Banazak et al. | The challenge and promise of decolonial thought to Biblical interpretation | |
| NO20061343L (no) | Imidazo[4,5-b]pyridinderivater som induserbare NO-syntaseinhibitorer | |
| Chen et al. | New oxoaporphine alkaloids from Hernandia nymphaeifolia |